Safety Reporting

Current section refers to the item 4.11 Safety Reporting of the INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2). It provides an overview of requirements for reporting of Serious Adverse Events occurring during a clinical trial.

 

4.11.1 All serious adverse events (SAEs) should be reported immediately to the sponsor except for those SAEs that the protocol or other document (e.g., Investigator's Brochure) identifies as not needing immediate reporting. The immediate reports should be followed promptly by detailed, written reports.

The immediate and follow-up reports should identify subjects by unique code numbers assigned to the trial subjects rather than by the subjects' names, personal identification numbers, and/or addresses.

The investigator should also comply with the applicable regulatory requirement(s) related to the reporting of unexpected serious adverse drug reactions to the regulatory authority(ies) and the IRB/IEC.

4.11.2 Adverse events and/or laboratory abnormalities identified in the protocol as critical to safety evaluations should be reported to the sponsor according to the reporting requirements and within the time periods specified by the sponsor in the protocol.

4.11.3 For reported deaths, the investigator should supply the sponsor and the IRB/IEC with any additional requested information (e.g., autopsy reports and terminal medical reports).

Clinical Research News

Eén prik tegen artrose? Wetenschappers melden gewrichtsherstel bij dieren binnen enkele weken
Pfizer to Test New Pneumococcal Vaccine for Children Needing Catch-up Immunization
Tuberculosebehandeling is een lange marathon. Een nieuwe studie test of deze tot 17 weken kan worden verkort
Na een diagnose diabetes type 1 begint de race tegen de klok. Een nieuwe studie probeert de eigen insuline te behouden
Hoe laag moet "slecht" cholesterol zijn? Studie test nieuw doelwit voor hoogrisicopatiënten
DYNE-251 getest in Fase 3-studie bij patiënten met Duchenne Musculaire Dystrofie
Orale GLP-1 wordt getest bij mensen met diabetes type 2 die vasten tijdens de Ramadan

Aankomende klinische onderzoeken

Clinical Research Jobs

More jobs

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren